NXTCL:STO
NextCell Pharma AB
SEK 1.00
arrow_downward
-1.96%(-0.020) 1D
Oct 8, 5:20:27 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NXTCL...
Open
SEK 1.00
High
SEK 1.01
Low
SEK 0.97
Mkt. cap
126.39M
Avg. vol.
368.75K
Volume
239.58K
52-wk high
SEK 1.78
52-wk low
SEK 0.63
EPS
-SEK 0.45
Shares outstanding
111.39M
No. of employees
21
Open
SEK 1.00
High
SEK 1.01
Low
SEK 0.97
Mkt. cap
126.39M
Avg. vol.
368.75K
Volume
239.58K
52-wk high
SEK 1.78
52-wk low
SEK 0.63
EPS
-SEK 0.45
Shares outstanding
111.39M
No. of employees
21
News stories
From web sources and news partners
Yahoo Finance
·
22 minutes ago
Bending Spoons (NasdaqGS:BSP) Taps Credit Markets Again As Its Undervalued Narrative Gets Tested
TradingView
·
11 minutes ago
Dow, S&P 500, Nasdaq Futures Climb After OpenAI’s Tepid Revenue Sparks Tech Selloff: NBIS, SPCX, T, VZ Stocks In Focus
The Dark Side Of The Boom
·
55 minutes ago
The S&P 500 Is Still Standing but the Foundations Are Starting to Crack
Profile
NextCell Pharma AB is a Swedish biopharmaceutical company headquartered in Huddinge, in the Flemingsberg life-science cluster south of Stockholm. The company develops allogeneic mesenchymal stromal cell therapies, with its lead candidate aimed at preserving insulin production in newly diagnosed type 1 diabetes. Alongside its drug development programme, NextCell operates a private umbilical cord stem cell bank and a contract manufacturing and analytical services subsidiary for Advanced Therapy Medicinal Products. NextCell's shares trade on the Nasdaq First North Growth Market in Stockholm under the ticker NXTCL. Wikipedia
About NextCell Pharma AB
CEOMathias Svahn
Employees21
FoundedMar 19, 2014
Headquarters-
SectorBiotechnology
Websitenextcellpharma.com